See other companies on Welcome to the Jungle
Cambridge Cognition
Neuroscience technology
- 21-100 employees
- Healthcare
- B2B
- SaaS
- MedTech
- Bottisham, UK
Jump to section
Company mission
To improve patient outcomes by providing the technology to better understand, detect and treat conditions affecting brain health.
Our take
Neuroscience is one of the most important frontiers of modern medical research, and Cambridge Cognition sets out to help us learn about the brain more quickly, easily and efficiently than ever before.
It uses cost-effective technology to improve the outcomes of clinical trials by offering large-scale, virtual patient screening meaning you have the best set of patients for your trial, but also by offering consulting services to help optimise the design of your trial. As well as this, Cambridge Cognition run fully remote clinical trials, revolutionising the way medical research is done in an increasingly remote-first world.
It already works with some of the world’s top pharmaceutical companies, including Pfizer, gsk and the NHS, and recent acquisitions put it in an even better place to lead the market in virtual clinical trials.
Steph
Company Specialist at Welcome to the Jungle
Benefits
- Flexibility, with in Bottisham just outside Cambridge, we are trialling hybrid work and see the value in having time together working in the office and time at home
- 26 days annual leave per year plus bank holidays
- Generous pension with up to 6.5% company contribution
- Life assurance 2x base salary
- Private Health Insurance - Bupa Insurance, Simply Health Cashback Scheme
- Share options – a % of base salary, with nominal exercise price and vesting over 3 years (subject to board approval)
Funding (last 2 of 3 rounds)
Feb 2018
$0.2m
GRANT
Aug 2017
$0.4m
GRANT
Total funding: $0.8m
This company has top investors